MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom

IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer test available to Lab21 Clinical Laboratory’s urology clients in the United Kingdom. MDxH-Lab 21 agreement PR ENG

Visit Page

NOVAprep® Regulatory Update in US and China Expands Commercial Reach

Novacyt – NOVAprep® Regulatory Update in US and China ENGLISH Paris, France and Cambridge, UK – 23rd February 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces a regulatory update for its next generation NOVAprep® technology platform in the US and China.

Visit Page